401 related articles for article (PubMed ID: 10920185)
1. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
Claassen GF; Hann SR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
3. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
4. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
[TBL] [Abstract][Full Text] [Related]
5. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
8. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
9. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
11. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
[TBL] [Abstract][Full Text] [Related]
12. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
13. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
14. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Mitchell KO; El-Deiry WS
Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
[TBL] [Abstract][Full Text] [Related]
16. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
19. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Kidd M; Modlin IM; Pfragner R; Eick GN; Champaneria MC; Chan AK; Camp RL; Mane SM
Cancer; 2007 Jun; 109(12):2420-31. PubMed ID: 17469181
[TBL] [Abstract][Full Text] [Related]
20. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
